Blue Jet Healthcare Ltd. ||Q4 FY25 Results
📊 Blue Jet Healthcare Ltd. ||
Q4 FY25 Results
➡️ Revenue from Operations
₹340.05 crore (QoQ: +6.8%, YoY: +84.9%)
➡️ Profit Before Tax (PBT)
₹147.22 crore (QoQ: +11.0%, YoY: +171.9%)
➡️ Net Profit (PAT)
₹110.10 crore (QoQ: +11.2%, YoY: +177.6%)
➡️ Earnings Per Share (EPS)
₹6.35 (QoQ: +11.2%, YoY: +177.3%)
🔹 Overall Verdict: Blockbuster
➤ Robust growth across topline and bottom line with sustained margin strength and operating efficiency.
🔍 What the Numbers Say
🔹 Revenue Performance
➤ Strong YoY revenue surge (+85%) driven by growth across sweeteners, contrast media intermediates, and pharma APIs. QoQ sequential uptick (+6.8%) despite Q4 seasonality reflects resilient volume and/or price growth.
🔹 Profitability Insights
➤ PBT more than doubled YoY. Impact of depreciation method change (WDV to SLM) enhanced PBT by ₹35.87 crore in Q4. Margins benefited from scale, operating leverage, and stable input costs.
🔹 Cost & Efficiency
➤ Controlled employee and finance costs. Operating margins expanded, and depreciation declined due to accounting method change, which boosted profitability.
🔹 Strategic / Operational Highlights
➤ Final dividend of ₹1.2/share declared.
➤ Fund raise of up to ₹1,500 crore approved via QIP/preferential issue.
➤ Land acquisition at Dahej for capacity expansion.
➤ Appointment of new senior leadership to drive strategy.
Comments
Post a Comment